Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.
Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.
Lol.
And ceo billioner defends company
Half million shares sold at .14. Ridiculous
I agree totally. Basically news do not tells us anything and shares are coming from somewhere.
Wondering what is cheap here?
Yeah right. From 1.60 to 0.14. Chart looks awesome. Stock lost more then 90% of value in couple months
I don’t believe them nothing. Nobody has this many shares to sell for few months already. It’s you or them.
Most likely company or 2 of those guys selling.
What a scam!
Strange company. CEO posts on this board but no news! Weird. Also they would get royalty of 5% if bizjet ever succeeds. Not sure how that works.
This is great come back for TXHG
I agree. I’m guessing they might start this year with actual press releases.
How many companies you can find profitable and just penny. They also do not dilute. This is golden. With some volume this could go to 5 to 10 cents where it was with this kind of revenues and profits.
Texas holdings profitable and under penny. 10Q out today
TXHG profitable and under penny
TXHG profitable and under penny.
10Q out. Profitable again.
I don’t believe nothing from that guy. He will do anything to screw people around.
LOL that’s a good one
Well I hope he gets in jail one day.
Wish I had listened you! He only knows how to screw people. Live and learn.
This could be break out year for ADMT! Product will be coming out.
Finally pulled trigger and took loss on this POS. Bradly really screed is all here. Sob probably used money for his company.
Sell off
Big news this morning.
ADM Tronics Accepted for Membership in MTEC - Medical Technology Enterprise Consortium
Source: InvestorsHub NewsWire
ADM Tronics Accepted for Membership in MTEC - Medical Technology Enterprise Consortium
Northvale, NJ -- November 08, 2018 -- InvestorsHub NewsWire -- ADM Tronics Unlimited, Inc. (OTCQB: ADMT) has been accepted for membership in the Medical Technology Enterprise Consortium (“MTEC”), a 501(c)3 biomedical technology consortium collaborating with multiple government agencies to foster integrated research partnerships to speed availability of medical technology solutions to the military, veterans and the civilian population.
ADMT’s expertise in the research, development and commercialization of therapeutic and diagnostic innovative medical device technologies aligns with the mission and goals of MTEC. MTEC membership is comprised of a wide range of organizations, including large companies, small businesses, academic research institutions and non-profit organizations. MTEC facilitates collaboration among its members and government agencies on biomedical research and development across all areas of military medicine.
“We are pleased to now be part of MTEC and look forward to opportunities to apply our medical technology development capabilities and experience to help optimize the health and performance of America’s active duty and military veterans,” stated Andre’ DiMino, President of ADMT.
As previously announced, ADMT is currently in development of three of its own proprietary therapeutic medical technologies which could have application in military medicine. These include the Alvio™ Respiratory Therapy platform; the Aurex-3® tinnitus treatment modality; and, the Sonotron® musculoskeletal pain therapy system.
On October 15, 2018 ADMT announced that it has completed development and engineering to bring the Alvio™ respiratory technology into production ready status with the initial 100-unit production run being assembled now. These initial Alvio production units are slated for user and clinic testing, including testing at the Mayo Clinic under the direction of Dr. Bruce Johnson. Dr. Johnson has dedicated his research to improving treatment of patients with pulmonary conditions. Research prototypes of the Alvio platform were previously successfully evaluated in Dr. Johnson’s lab.
In addition to its own technologies, ADMT has developed medical device technologies for third-party customers which may also have application in military biomedical research and development.
“The diverse areas of medical technology areas we have been involved with over many years gives us a broad base of experience in electronic biomedical technologies which we believe can be very helpful in potential collaborations developed through our membership in MTEC,” commented Mr. DiMino.
ADM Tronics Accepted for Membership in MTEC - Medical Technology Enterprise Consortium
Source: InvestorsHub NewsWire
ADM Tronics Accepted for Membership in MTEC - Medical Technology Enterprise Consortium
Northvale, NJ -- November 08, 2018 -- InvestorsHub NewsWire -- ADM Tronics Unlimited, Inc. (OTCQB: ADMT) has been accepted for membership in the Medical Technology Enterprise Consortium (“MTEC”), a 501(c)3 biomedical technology consortium collaborating with multiple government agencies to foster integrated research partnerships to speed availability of medical technology solutions to the military, veterans and the civilian population.
ADMT’s expertise in the research, development and commercialization of therapeutic and diagnostic innovative medical device technologies aligns with the mission and goals of MTEC. MTEC membership is comprised of a wide range of organizations, including large companies, small businesses, academic research institutions and non-profit organizations. MTEC facilitates collaboration among its members and government agencies on biomedical research and development across all areas of military medicine.
“We are pleased to now be part of MTEC and look forward to opportunities to apply our medical technology development capabilities and experience to help optimize the health and performance of America’s active duty and military veterans,” stated Andre’ DiMino, President of ADMT.
As previously announced, ADMT is currently in development of three of its own proprietary therapeutic medical technologies which could have application in military medicine. These include the Alvio™ Respiratory Therapy platform; the Aurex-3® tinnitus treatment modality; and, the Sonotron® musculoskeletal pain therapy system.
On October 15, 2018 ADMT announced that it has completed development and engineering to bring the Alvio™ respiratory technology into production ready status with the initial 100-unit production run being assembled now. These initial Alvio production units are slated for user and clinic testing, including testing at the Mayo Clinic under the direction of Dr. Bruce Johnson. Dr. Johnson has dedicated his research to improving treatment of patients with pulmonary conditions. Research prototypes of the Alvio platform were previously successfully evaluated in Dr. Johnson’s lab.
In addition to its own technologies, ADMT has developed medical device technologies for third-party customers which may also have application in military biomedical research and development.
“The diverse areas of medical technology areas we have been involved with over many years gives us a broad base of experience in electronic biomedical technologies which we believe can be very helpful in potential collaborations developed through our membership in MTEC,” commented Mr. DiMino.
ADM Tronics Accepted for Membership in MTEC - Medical Technology Enterprise Consortium
Source: InvestorsHub NewsWire
ADM Tronics Accepted for Membership in MTEC - Medical Technology Enterprise Consortium
Northvale, NJ -- November 08, 2018 -- InvestorsHub NewsWire -- ADM Tronics Unlimited, Inc. (OTCQB: ADMT) has been accepted for membership in the Medical Technology Enterprise Consortium (“MTEC”), a 501(c)3 biomedical technology consortium collaborating with multiple government agencies to foster integrated research partnerships to speed availability of medical technology solutions to the military, veterans and the civilian population.
ADMT’s expertise in the research, development and commercialization of therapeutic and diagnostic innovative medical device technologies aligns with the mission and goals of MTEC. MTEC membership is comprised of a wide range of organizations, including large companies, small businesses, academic research institutions and non-profit organizations. MTEC facilitates collaboration among its members and government agencies on biomedical research and development across all areas of military medicine.
“We are pleased to now be part of MTEC and look forward to opportunities to apply our medical technology development capabilities and experience to help optimize the health and performance of America’s active duty and military veterans,” stated Andre’ DiMino, President of ADMT.
As previously announced, ADMT is currently in development of three of its own proprietary therapeutic medical technologies which could have application in military medicine. These include the Alvio™ Respiratory Therapy platform; the Aurex-3® tinnitus treatment modality; and, the Sonotron® musculoskeletal pain therapy system.
On October 15, 2018 ADMT announced that it has completed development and engineering to bring the Alvio™ respiratory technology into production ready status with the initial 100-unit production run being assembled now. These initial Alvio production units are slated for user and clinic testing, including testing at the Mayo Clinic under the direction of Dr. Bruce Johnson. Dr. Johnson has dedicated his research to improving treatment of patients with pulmonary conditions. Research prototypes of the Alvio platform were previously successfully evaluated in Dr. Johnson’s lab.
In addition to its own technologies, ADMT has developed medical device technologies for third-party customers which may also have application in military biomedical research and development.
“The diverse areas of medical technology areas we have been involved with over many years gives us a broad base of experience in electronic biomedical technologies which we believe can be very helpful in potential collaborations developed through our membership in MTEC,” commented Mr. DiMino.
I see this explode to mid 20s like admt did.
I see this explode to mid 20s like admt did.
Sell off
Really and how you know this. I’ll take my chances on shares that I purchased below penny.
With this share structure this is also good company for merger
Who knows. This is very strange though
Hope so.
I have no idea.
Nite at 6 cents and then maxm at 26 cents. Wow
I have no idea. Just saw this.